Chromosomal rearrangements in tumors resulting in RET gene fusions are found in 1–2% of unselected patients with lung adenocarcinoma, and in 6–14% of adenocarcinomas wild-type for other known molecular drivers (11). Here, RET is linked to adenocarcinoma.